These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 30178092

  • 21. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
    Wong F, Boyer TD, Sanyal AJ, Pappas SC, Escalante S, Jamil K.
    Nephrol Dial Transplant; 2020 Sep 01; 35(9):1554-1561. PubMed ID: 30887050
    [Abstract] [Full Text] [Related]

  • 22. COST EFFECTIVENESS OF USING TERLIPRESSIN TO TREAT HEPATORENAL SYNDROME.
    Ferreira LM, Terrabuio DR, Ferreira CM, Mazo DFC, Haddad LBP.
    Arq Gastroenterol; 2022 Sep 01; 59(2):268-274. PubMed ID: 35830040
    [Abstract] [Full Text] [Related]

  • 23. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.
    Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P, Terlipressin Study Group.
    J Hepatol; 2011 Aug 01; 55(2):315-21. PubMed ID: 21167235
    [Abstract] [Full Text] [Related]

  • 24. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome.
    Hinz M, Wree A, Jochum C, Bechmann LP, Saner F, Gerbes AL, Gerken G, Canbay A.
    Ann Hepatol; 2013 Aug 01; 12(1):92-9. PubMed ID: 23293199
    [Abstract] [Full Text] [Related]

  • 25. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC, REVERSE Study Investigators.
    Gastroenterology; 2016 Jun 01; 150(7):1579-1589.e2. PubMed ID: 26896734
    [Abstract] [Full Text] [Related]

  • 26. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S, Gambino C, Vettore E, Calvino V, Tonon M, Boccagni P, Gringeri E, Germani G, Burra P, Cillo U, Angeli P.
    Hepatology; 2021 May 01; 73(5):1909-1919. PubMed ID: 32870499
    [Abstract] [Full Text] [Related]

  • 27. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
    Sagi SV, Mittal S, Kasturi KS, Sood GK.
    J Gastroenterol Hepatol; 2010 May 01; 25(5):880-5. PubMed ID: 20074149
    [Abstract] [Full Text] [Related]

  • 28. Terlipressin therapy for renal failure in cirrhosis.
    Triantos CK, Samonakis D, Thalheimer U, Cholongitas E, Senzolo M, Marelli L, Leandro G, Patch D, Burroughs AK.
    Eur J Gastroenterol Hepatol; 2010 Apr 01; 22(4):481-6. PubMed ID: 19952764
    [Abstract] [Full Text] [Related]

  • 29. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
    Erstad BL.
    Ann Pharmacother; 2024 Feb 01; 58(2):156-164. PubMed ID: 37271967
    [Abstract] [Full Text] [Related]

  • 30. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    Israelsen M, Krag A, Allegretti AS, Jovani M, Goldin AH, Winter RW, Gluud LL.
    Cochrane Database Syst Rev; 2017 Sep 27; 9(9):CD011532. PubMed ID: 28953318
    [Abstract] [Full Text] [Related]

  • 31. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
    Olson JC, Subramanian RM.
    PLoS One; 2024 Sep 27; 19(1):e0296690. PubMed ID: 38285703
    [Abstract] [Full Text] [Related]

  • 32. Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
    Nassar Junior AP, Farias AQ, D' Albuquerque LA, Carrilho FJ, Malbouisson LM.
    PLoS One; 2014 Sep 27; 9(9):e107466. PubMed ID: 25203311
    [Abstract] [Full Text] [Related]

  • 33. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial.
    Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK.
    J Gastroenterol Hepatol; 2003 Feb 27; 18(2):152-6. PubMed ID: 12542598
    [Abstract] [Full Text] [Related]

  • 34. Terlipressin and albumin combination treatment in hepatorenal syndrome.
    Danalioglu A, Cakaloglu Y, Karaca C, Aksoy N, Akyuz F, Ozdil S, Demir K, Besisik F, Boztas G, Mungan Z, Kaymakoglu S, Okten A.
    Hepatogastroenterology; 2003 Dec 27; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
    [Abstract] [Full Text] [Related]

  • 35. Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials.
    Fabrizi F, Dixit V, Messa P, Martin P.
    Int J Artif Organs; 2009 Mar 27; 32(3):133-40. PubMed ID: 19440988
    [Abstract] [Full Text] [Related]

  • 36. Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome.
    Wong F, Pappas SC, Boyer TD, Sanyal AJ, Bajaj JS, Escalante S, Jamil K, REVERSE Investigators.
    Clin Gastroenterol Hepatol; 2017 Feb 27; 15(2):266-272.e1. PubMed ID: 27464593
    [Abstract] [Full Text] [Related]

  • 37. Vasoactive Agents for Hepatorenal Syndrome: A Mixed Treatment Comparison Network Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials.
    Sridharan K, Sivaramakrishnan G.
    J Gen Intern Med; 2018 Jan 27; 33(1):97-102. PubMed ID: 28924736
    [Abstract] [Full Text] [Related]

  • 38. Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Thomson MJ, Taylor A, Sharma P, Lok AS, Tapper EB.
    Dig Dis Sci; 2020 May 27; 65(5):1539-1548. PubMed ID: 31571102
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
    Rodríguez E, Elia C, Solà E, Barreto R, Graupera I, Andrealli A, Pereira G, Poca M, Sánchez J, Guevara M, Soriano G, Alessandria C, Fernández J, Arroyo V, Ginès P.
    J Hepatol; 2014 May 27; 60(5):955-61. PubMed ID: 24447876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.